Old West Investment Management, LLC Atara Biotherapeutics, Inc. Transaction History

Old West Investment Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$19.05 - $41.04 $184,118 - $396,651	-9,665 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$30.9 - $42.97 $9,857 - $13,707	-319 Reduced 3.2%	9,665 $335,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $1,542 - $1,914	-44 Reduced 0.44%	9,984 $412,000
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $11,740 - $17,184	334 Added 3.45%	10,028 $368,000
Q1 2018 May 16, 2018	SELL	$18.0 - $48.35 $167,688 - $450,428	-9,316 Reduced 49.01%	9,694 $378,000
Q4 2017 Feb 14, 2018	SELL	$13.2 - $18.1 $24,882 - $34,118	-1,885 Reduced 9.02%	19,010 $344,000
Q3 2017 Nov 14, 2017	BUY	$13.25 - $17.05 $276,858 - $356,259	20,895	20,895 $345,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $795M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Old West Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Old West Investment Management, LLC with notifications on news.